Study Approved for Paindrainer’s Digital Medical Device

Paindrainer AB has received the necessary approval to study its digital medical device’s impact on brain activities. 

The Paindrainer medical device will be used in the study to investigate the ways in which chronic pain is processed in the brain—using Cleveland Clinic’s established brain scanning technology—and evaluate the correlation between users’ logged data and objectively measured real world data through wearables. The study will be held at Cleveland Clinic in collaboration with Lund University in Sweden. 

“It is a unique opportunity and very encouraging that Paindrainer will be the digital medical device of choice in this study, investing how changes in EEG features are correlated with the reduction of chronic pain. In addition, correlation between users’ logged data and objectively measured data using wearables will be evaluated. This will be of great value as we explore the integration of wearables in coming versions of Paindrainer,” Paindrainer AB CEO Erik Frick said. 

The Paindrainer mobile application is the first evidence-based digital tool demonstrating improved quality of life for those living with chronic pain. The product is registered with the U.S. Food and Drug Administration as a class I medical device. The solution is powered by leveraging advanced algorithms and is fully adaptive to each individual patient, featuring the proprietary 360-degree patient-centric approach. This approach provides guidance on ways to achieve a personalized activity balance to reach an optimal functional level and alleviate pain.

Paindrainer AB is a company developing digital platforms and applications contributing to health and well-being. Paindrainer was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors. The idea was born when Maria, after participating in several pain rehabilitation programs, realized that pain is affected by many more factors than the human brain can comprehend. 

Paindrainer is the first evidence-based artificial intelligence-powered digital tool demonstrating improved quality of life in individuals living with chronic pain. The digital tool coaches the users in managing their pain and provides guidance on possible methods to attain a personalized activity balance to reach an optimal functional level and alleviate pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each user, a feature called 360-degree patient-centricity.

Paindrainer (Paindrainer PD1) is MDR compliant and CE mark certified.